×
Taysha Gene Therapies Net Profit Margin 2020-2024 | TSHA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Taysha Gene Therapies net profit margin from 2020 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Taysha Gene Therapies Net Profit Margin 2020-2024 | TSHA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Taysha Gene Therapies net profit margin from 2020 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.6B
Dr Reddy's Laboratories (RDY)
$11.6B
BridgeBio Pharma (BBIO)
$6.2B
Bausch Health Cos (BHC)
$2.4B
Supernus Pharmaceuticals (SUPN)
$2.1B
Amphastar Pharmaceuticals (AMPH)
$1.6B
Personalis (PSNL)
$365M
Assembly Biosciences (ASMB)
$87M
Sol-Gel Technologies (SLGL)
$19M
Evoke Pharma (EVOK)
$7M
Teligent (TLGT)
$0M